[PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Toombs, James A ^a,b   Liss, Nathan M ^a   Cobble, Kacy R ^a   Ben Musa, Zobaida ^a   Ross, Eric D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; PRION PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; SUP35 PROTEIN; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN; HSP104 PROTEIN, S CEREVISIAE; HYBRID PROTEIN; MUTANT PROTEIN; OLIGOPEPTIDE; SUP35 PROTEIN, S CEREVISIAE; TRANSLATION TERMINATION FACTOR;

AMINO ACID ANALYSIS; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE DELETION; NONHUMAN; OLIGOPEPTIDE REPEAT DOMAIN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PRION; PROTEIN TERTIARY STRUCTURE;

MAMMALIAN PRION;

AMINO ACID SEQUENCE; HEAT-SHOCK PROTEINS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; OLIGOPEPTIDES; PEPTIDE TERMINATION FACTORS; PRIONS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 79960104526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021953     Document Type: Article

References (54)

1. Wickner RB, Shewmaker F, Edskes H, Kryndushkin D, Nemecek J, et al. (2010) Prion amyloid structure explains templating: how proteins can be genes. FEMS Yeast Res 10: 980-991.
2. Tessier PM, Lindquist S, (2009) Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nat Struct Mol Biol 16: 598-605.
3. Wickner RB, (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566-569.
4. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, et al. (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14: 4365-4373.
5. Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, et al. (1995) Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 14: 4065-4072.
6. Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN, (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137: 671-676.
7. Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, et al. (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7: 683-692.
8. DePace AH, Santoso A, Hillner P, Weissman JS, (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93: 1241-1252.
9. Liu JJ, Sondheimer N, Lindquist SL, (2002) Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99 (Suppl 4): 16446-16453.
10. Osherovich LZ, Cox BS, Tuite MF, Weissman JS, (2004) Dissection and design of yeast prions. PLoS Biol 2: E86.
11. Liu JJ, Lindquist S, (1999) Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400: 573-576.
12. Parham SN, Resende CG, Tuite MF, (2001) Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 20: 2111-2119.
13. Shkundina IS, Kushnirov VV, Tuite MF, Ter-Avanesyan MD, (2006) The role of the N-terminal oligopeptide repeats of the yeast sup35 prion protein in propagation and transmission of prion variants. Genetics 172: 827-835.
14. Ohhashi Y, Ito K, Toyama BH, Weissman JS, Tanaka M, (2010) Differences in prion strain conformations result from non-native interactions in a nucleus. Nature 6: 225-230.
15. Crist CG, Nakayashiki T, Kurahashi H, Nakamura Y, (2003) [PHI+], a novel Sup35-prion variant propagated with non-Gln/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104. Genes Cells 8: 603-618.
16. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW, (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880-884.
17. Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR, (2010) A size threshold limits prion transmission and establishes phenotypic diversity. Science 330: 680-683.
18. Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YO, (2001) Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 21: 4656-4669.
19. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD, (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15: 3127-3134.
20. Ness F, Ferreira P, Cox BS, Tuite MF, (2002) Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22: 5593-5605.
21. Nakayashiki T, Ebihara K, Bannai H, Nakamura Y, (2001) Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol Cell 7: 1121-1130.
22. Ross ED, Edskes HK, Terry MJ, Wickner RB, (2005) Primary sequence independence for prion formation. Proc Natl Acad Sci USA 102: 12825-12830.
23. Street AG, Mayo SL, (1999) Intrinsic beta-sheet propensities result from van der Waals interactions between side chains and the local backbone. Proc Natl Acad Sci U S A 96: 9074-9076.
24. Toombs JA, McCarty BR, Ross ED, (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30: 319-332.
25. Wadsworth JD, Hill AF, Beck JA, Collinge J, (2003) Molecular and clinical classification of human prion disease. Br Med Bull 66: 241-254.
26. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE, (1998) Prion protein biology. Cell 93: 337-348.
27. Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, et al. (2000) Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27: 399-408.
28. Dong J, Bloom JD, Goncharov V, Chattopadhyay M, Millhauser GL, et al. (2007) Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions. J Biol Chem 282: 34204-34212.
29. Tank EM, Harris DA, Desai AA, True HL, (2007) Prion protein repeat expansion results in increased aggregation and reveals phenotypic variability. Mol Cell Biol 27: 5445-5455.
30. Kalastavadi T, True HL, (2008) Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem 9: 7.
31. Vitrenko YA, Pavon ME, Stone SI, Liebman SW, (2007) Propagation of the [PIN+] prion by fragments of Rnq1 fused to GFP. Curr Genet 51: 309-319. Epub 2007 Apr 2006.
32. Nemecek J, Nakayashiki T, Wickner RB, (2009) A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen. Proc Natl Acad Sci U S A 106: 1892-1896.
33. Sondheimer N, Lindquist S, (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5: 163-172.
34. Douglas PM, Treusch S, Ren HY, Halfmann R, Duennwald ML, et al. (2008) Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci U S A 105: 7206-7211.
35. Shorter J, Lindquist S, (2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304: 1793-1797.
36. Schlumpberger M, Prusiner SB, Herskowitz I, (2001) Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 21: 7035-7046.
37. Cox BS, (1965) PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 26: 211-232.
38. Tuite MF, Mundy CR, Cox BS, (1981) Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 98: 691-711.
39. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF, (2001) The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40: 1357-1369.
40. Jung G, Masison DC, (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr Microbiol 43: 7-10.
41. Jung G, Jones G, Masison DC, (2002) Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion- curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci USA 99: 9936-9941.
42. Toyama BH, Kelly MJ, Gross JD, Weissman JS, (2007) The structural basis of yeast prion strain variants. Nature 449: 233-237.
43. Esteras-Chopo A, Serrano L, de la Paz ML, (2005) The amyloid stretch hypothesis: Recruiting proteins toward the dark side. Proc Natl Acad Sci USA 102: 16672-16677.
44. Ross ED, Toombs JA, (2010) The effects of amino acid composition on yeast prion formation and prion domain interactions. Prion 4: 60-65.
45. Antzutkin ON, Leapman RD, Balbach JJ, Tycko R, (2002) Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41: 15436-15450.
46. Yuan C, Berscheit HL, Huang AJW, (2007) Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. FEBS Letters 581: 241-247.
47. Alexandrov IM, Vishnevskaya AB, Ter-Avanesyan MD, Kushnirov VV, (2008) Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation. J Biol Chem 283: 15185-15192.
48. Romanova NV, Chernoff YO, (2009) Hsp104 and prion propagation. Protein Pept Lett 16: 598-605.
49. Shorter J, (2008) Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 16: 63-74. Epub 2007 Dec 2005.
50. Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, et al. (1992) Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115: 687-710.
51. Poulter M, Baker HF, Frith CD, Leach M, Lofthouse R, et al. (1992) Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 115: 675-685.
52. Sherman F, (1991) Getting started with yeast. Methods Enzymol 194: 3-21.
53. Song Y, Wu YX, Jung G, Tutar Y, Eisenberg E, et al. (2005) Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication. Eukaryot Cell 4: 289-297.
54. Ross CD, McCarty BM, Hamilton M, Ben-Hur A, Ross ED, (2009) A promiscuous prion: Efficient induction of [URE3] prion formation by heterologous prion domains. Genetics 183: 929-940.